Prodia (PRDA IJ) - New Outlets and Esoteric Testing Driving Growth
Prodia (PRDA IJ) is starting to see its growth strategy gain traction with a QoQ increase in 2Q2024 revenues driven by more esoteric testing and...
321 Views
Prodia (PRDA IJ) - Increasingly Esoteric
Prodia is shifting in a meaningful way towards esoteric testing, which commands significantly higher revenues plus it is building out its genomic...
199 Views
Prodia (PRDA IJ) - Back to Core Testing
Prodia (PRDA IJ) FY2022 results saw declines in revenues and profits but from a COVID-high base and the numbers are now well-above 2019, with...
479 Views
Prodia (PRDA IJ) - A Standout in Diagnostics
Prodia (PRDA IJ) stands out in terms of its strong market positioning and track record together with attractive valuations, especially versus...
345 Views
Prodia (PRDA IJ) - Diagnosing a Return to Healthy Profits
Prodia (PRDA IJ) is significantly cheaper than its Indian comparables, trading on half the valuation, despite being a high-quality player tapping...
560 Views